I have pruritus after starting Tessalon (benzonatate); how should I manage it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Benzonatate (Tessalon Perles)-Induced Pruritus

Discontinue benzonatate immediately, as pruritus represents a drug-induced adverse reaction that requires cessation of the causative medication. 1, 2

Immediate Action

  • Stop benzonatate (Tessalon Perles) immediately upon recognition of pruritus, as this is the fundamental principle of managing drug-induced itch 1, 2
  • Drug-induced pruritus is defined as generalized itching without skin lesions caused by a medication, and the primary treatment is discontinuation of the suspected causative drug 2
  • Assess whether there are any skin lesions present; if absent, this confirms drug-induced pruritus rather than a drug-induced rash 2
  • Evaluate the severity and timing: note when pruritus started relative to benzonatate initiation and whether it is localized or generalized 1

Symptomatic Management While Pruritus Resolves

For Mild Localized Pruritus (Grade 1)

  • Apply moderate-potency topical corticosteroids such as mometasone furoate 0.1% or betamethasone valerate 0.1% ointment to affected areas 1
  • Use emollients regularly to maintain skin hydration and prevent xerosis, which can worsen itching 1, 3
  • Consider topical menthol 0.5% for additional symptomatic relief through counter-irritant effects 1
  • Monitor for 2 weeks; if symptoms worsen or persist, escalate treatment 1

For Moderate to Severe Pruritus (Grade 2)

  • Non-sedating antihistamines for daytime use: loratadine 10 mg once daily or fexofenadine 180 mg once daily 1, 3
  • Sedating antihistamines for nighttime use: hydroxyzine 25-50 mg at bedtime or diphenhydramine 25-50 mg at bedtime to break the itch-scratch cycle 1, 4
  • Continue topical corticosteroids and emollients as above 1
  • Reassess after 2 weeks; if no improvement, proceed to next step 1

For Refractory or Severe Pruritus (Grade 3)

  • GABA agonists as second-line systemic therapy: gabapentin 900-3600 mg daily or pregabalin 25-150 mg daily 1, 3
  • Start gabapentin at lower doses and titrate upward based on response and tolerability 3
  • Tricyclic antidepressant doxepin 10 mg twice daily may be considered as an alternative, particularly if antihistamines fail 3, 4
  • Consider dermatology referral if symptoms remain refractory to these interventions 4

Critical Pitfalls to Avoid

  • Do not continue benzonatate even if pruritus is mild, as drug-induced reactions can progress unpredictably 1, 2
  • Do not use topical corticosteroids for more than 2 weeks continuously without reassessment, as prolonged use can cause skin atrophy 1
  • Avoid long-term sedating antihistamines (beyond what is needed for symptom resolution) except in palliative care settings, as chronic use may increase dementia risk in elderly patients 3
  • Monitor for signs of DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms): fever, facial edema, lymphadenopathy, or systemic symptoms, which would require immediate medical evaluation and possible systemic corticosteroids 5

Expected Timeline

  • Pruritus typically resolves within days to weeks after discontinuation of the causative medication 2
  • If itching persists beyond 2-4 weeks after stopping benzonatate, investigate alternative causes of pruritus and consider specialist referral 1, 3
  • Vigorous symptomatic antipruritic treatment should be undertaken if the causative drug cannot be stopped or if itching persists after drug withdrawal 2

Alternative Cough Management

  • Discuss alternative antitussive options with the prescribing physician, as benzonatate should not be restarted given the adverse reaction 2
  • Consider non-pharmacologic measures or alternative cough suppressants that do not share cross-reactivity 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-Induced Itch Management.

Current problems in dermatology, 2016

Guideline

First-Line Pharmacotherapeutic Management of Pruritus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hydroxyzine for Pruritus Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.